(R)-N-(3-(3-(4,4-Difluoropiperidin-1-yl)-3-oxopropyl)-7-(3-(dimethylamino)phenoxy)-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)-2-((4-(trifluoromethyl)benzyl)oxy)acetamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (R)-N-(3-(3-(4,4-Difluoropiperidin-1-yl)-3-oxopropyl)-7-(3-(dimethylamino)phenoxy)-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)-2-((4-(trifluoromethyl)benzyl)oxy)acetamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(R)-N-(3-(3-(4,4-Difluoropiperidin-1-yl)-3-oxopropyl)-7-(3-(dimethylamino)phenoxy)-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)-2-((4-(trifluoromethyl)benzyl)oxy)acetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Nucleotide-binding oligomerization domain-containing protein 2 Protein (Entity type)	IC50
	(R)-N-(3-(3-(4,4-Difluoropiperidin-1-yl)-3-oxopropyl)-7-(3-(dimethylamino)phenoxy)-2,5-dioxo-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-8-yl)-2-((4-(trifluoromethyl)benzyl)oxy)acetamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Nucleotide-binding oligomerization domain-containing protein 1 Protein (Entity type)	IC50